GCAN-101 (GammaCan International)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGCAN-101 (GammaCan International)
Drug Alias NameIVIg-based therapyGCAN-101
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGammacan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGammacan
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A